Insider transactions

EDGAR

Beta Bionics, Inc.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-22.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
57 transactions, 290,199.00 shares
Sum of shares × price per share: 5,593,525.364

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 102

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-11-16 Filed 2026-11-18Hopman Mark Officer: Chief Commercial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)775.005.10
3,952.5

Derived: shares × price per share. Exact value 3952.5000.

54,918.00Direct (D) Yes— Open filing 0002048497-26-000027 Read from the filing’s XML Dispute this row
2026-11-16 Filed 2026-11-18Hopman Mark Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)775.0016.22
12,570.5

Derived: shares × price per share. Exact value 12570.5000.

54,143.00Direct (D) Yes
F1
  • F1 Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026.
Open filing 0002048497-26-000027 Read from the filing’s XML Dispute this row
2026-11-16 Filed 2026-11-18Hopman Mark Officer: Chief Commercial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (775.00) — exercise price 5.10
Disposed (D)775.000.00
0

Derived: shares × price per share. Exact value 0.0000.

20,950.00Direct (D) Yes
F2
  • F2 The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023.
Open filing 0002048497-26-000027 Read from the filing’s XML Dispute this row
2026-11-11 Filed 2026-11-13Feider Stephen Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)8,874.005.10
45,257.4

Derived: shares × price per share. Exact value 45257.4000.

168,252.00Direct (D) Yes— Open filing 0002048588-26-000019 Read from the filing’s XML Dispute this row
2026-11-11 Filed 2026-11-13Feider Stephen Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)8,874.0017.2054
152,680.7196

Derived: shares × price per share. Exact value 152680.719600.

159,378.00Direct (D) Yes
F1, F2
  • F1 Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2026.
  • F2 The weighted average sale price for the transaction reported was $17.2054 and the range of prices were between $17.00 and $17.55. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Open filing 0002048588-26-000019 Read from the filing’s XML Dispute this row
2026-11-11 Filed 2026-11-13Feider Stephen Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (8,874.00) — exercise price 5.10
Disposed (D)8,874.000.00
0

Derived: shares × price per share. Exact value 0.0000.

29,695.00Direct (D) Yes
F3
  • F3 The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023.
Open filing 0002048588-26-000019 Read from the filing’s XML Dispute this row
2026-11-09 Filed 2026-11-12Feider Stephen Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)744.005.10
3,794.4

Derived: shares × price per share. Exact value 3794.4000.

160,122.00Direct (D) Yes— Open filing 0002048588-26-000018 Read from the filing’s XML Dispute this row
2026-11-09 Filed 2026-11-12Feider Stephen Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)744.0017.0013
12,648.9672

Derived: shares × price per share. Exact value 12648.967200.

159,378.00Direct (D) Yes
F1, F2
  • F1 Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2026.
  • F2 The weighted average sale price for the transaction reported was $17.001344 and the range of prices were between $17.00 and $17.01. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Open filing 0002048588-26-000018 Read from the filing’s XML Dispute this row
2026-11-09 Filed 2026-11-12Feider Stephen Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (744.00) — exercise price 5.10
Disposed (D)744.000.00
0

Derived: shares × price per share. Exact value 0.0000.

38,569.00Direct (D) Yes
F3
  • F3 The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023.
Open filing 0002048588-26-000018 Read from the filing’s XML Dispute this row
2026-11-05 Filed 2026-11-09Feider Stephen Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)382.005.10
1,948.2

Derived: shares × price per share. Exact value 1948.2000.

159,760.00Direct (D) Yes— Open filing 0002048588-26-000015 Read from the filing’s XML Dispute this row
2026-11-05 Filed 2026-11-09Feider Stephen Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)382.0017.0366
6,507.9812

Derived: shares × price per share. Exact value 6507.981200.

159,378.00Direct (D) Yes
F1, F2
  • F1 Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2026.
  • F2 The weighted average sale price for the transaction reported was $17.036649 and the range of prices were between $17.00 and $17.07. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Open filing 0002048588-26-000015 Read from the filing’s XML Dispute this row
2026-11-05 Filed 2026-11-09Feider Stephen Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (382.00) — exercise price 5.10
Disposed (D)382.000.00
0

Derived: shares × price per share. Exact value 0.0000.

39,313.00Direct (D) Yes
F3
  • F3 The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023.
Open filing 0002048588-26-000015 Read from the filing’s XML Dispute this row
2026-11-02 Filed 2026-11-04Hopman Mark Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)370.0016.90
6,253

Derived: shares × price per share. Exact value 6253.0000.

54,143.00Direct (D) Yes
F1
  • F1 Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026.
Open filing 0002048497-26-000025 Read from the filing’s XML Dispute this row
2026-10-27 Filed 2026-10-29Mensinger Mike Officer: Chief Product Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,650.0022.00
58,300

Derived: shares × price per share. Exact value 58300.0000.

174,740.00Direct (D) Yes
F1
  • F1 Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on September 8, 2025.
Open filing 0002048500-26-000015 Read from the filing’s XML Dispute this row
2026-10-26 Filed 2026-10-28Hopman Mark Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)821.0020.00
16,420

Derived: shares × price per share. Exact value 16420.0000.

54,513.00Direct (D) Yes
F1
  • F1 Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026.
Open filing 0002048497-26-000023 Read from the filing’s XML Dispute this row
2026-10-14 Filed 2026-10-16Hopman Mark Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)775.0017.35
13,446.25

Derived: shares × price per share. Exact value 13446.2500.

55,334.00Direct (D) No
F1, F2
  • F1 Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026.
  • F2 The weighted average sale price for the transaction reported was $17.35 and the range of prices were between $17.35 and $18.3499. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Open filing 0002048497-26-000021 Read from the filing’s XML Dispute this row
2026-10-01 Filed 2026-10-05Hopman Mark Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)370.0018.96
7,015.2

Derived: shares × price per share. Exact value 7015.2000.

56,109.00Direct (D) No
F1, F2
  • F1 Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026.
  • F2 The weighted average sale price for the transaction reported was $18.96 and the range of prices were between $18.96 and $19.9599. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Open filing 0002048497-26-000018 Read from the filing’s XML Dispute this row
2026-09-22 Filed 2026-09-23Jones Christy Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)6,43023
147,890

Derived: shares × price per share. Exact value 147890.

19,564Direct (D) Yes
F1
  • F1 Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on February 19, 2026.
Open filing 0002048467-26-000007 Read from the filing’s XML Dispute this row
2026-09-16 Filed 2026-09-17Hopman Mark Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)30,77920.1319
619,639.7501

Derived: shares × price per share. Exact value 619639.7501.

56,479Direct (D) Yes
F1, F2
  • F1 Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026.
  • F2 The weighted average sale price for the transaction reported was $20.1319 and the range of prices were between $20.00 and $20.64. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Open filing 0002048497-26-000015 Read from the filing’s XML Dispute this row
2026-09-16 Filed 2026-09-17Mensinger Mike Officer: Chief Product Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,65022
58,300

Derived: shares × price per share. Exact value 58300.

177,390Direct (D) Yes
F1
  • F1 Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on September 8, 2025.
Open filing 0002048500-26-000013 Read from the filing’s XML Dispute this row
2026-09-14 Filed 2026-09-15Hopman Mark Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)77515.52
12,028

Derived: shares × price per share. Exact value 12028.00.

86,382Direct (D) Yes
F1
  • F1 Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026.
Open filing 0002048497-26-000014 Read from the filing’s XML Dispute this row
2026-09-09 Filed 2026-09-18Hopman Mark Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)35,99418.4628
664,550.0232

Derived: shares × price per share. Exact value 664550.0232.

88,033Direct (D) Yes
F1, F2
  • F1 Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026 (the 10b5-1 Plan).
  • F2 On September 10, 2026, the reporting person filed a Form 4 which incorrectly reported the number of shares disposed. The reporting person sold 35,994 shares under the 10b5-1 Plan on September 9, 2026 and the number of securities beneficially owned following the sale was 88,033 shares.
Open filing 0002048497-26-000016 Read from the filing’s XML Dispute this row
2026-09-09 Filed 2026-09-10Hopman Mark Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)36,87018.4628
680,723.436

Derived: shares × price per share. Exact value 680723.4360.

87,157Direct (D) Yes
F1
  • F1 Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on June 10, 2026.
Open filing 0002048497-26-000013 Read from the filing’s XML Dispute this row
2026-09-03 Filed 2026-09-04Saint Sean Director · Officer: President CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)5,64120.0778
113,258.8698

Derived: shares × price per share. Exact value 113258.8698.

398,429Direct (D) Yes
F1, F2
  • F1 Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on September 5, 2025.
  • F2 The weighted average sale price for the transaction reported was $20.0778 and the range of prices were between $20.00 and $20.1696. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Open filing 0002048593-26-000010 Read from the filing’s XML Dispute this row
2026-09-02 Filed 2026-09-03Hopman Mark Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)5,32719.1131
101,815.4837

Derived: shares × price per share. Exact value 101815.4837.

124,027Direct (D) No
F1, F2
  • F1 The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.
  • F2 The weighted average sale price for the transaction reported was $19.1131 and the range of prices were between $18.89 and $19.545. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Open filing 0002048497-26-000012 Read from the filing’s XML Dispute this row
2026-09-02 Filed 2026-09-03Feider Stephen Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)6,67519.1131
127,579.9425

Derived: shares × price per share. Exact value 127579.9425.

159,378Direct (D) No
F1, F2
  • F1 The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.
  • F2 The weighted average sale price for the transaction reported was $19.1131 and the range of prices were between $18.89 and $19.545. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Open filing 0002048588-26-000013 Read from the filing’s XML Dispute this row
2026-09-02 Filed 2026-09-03Mensinger Mike Officer: Chief Product Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)4,37519.1131
83,619.8125

Derived: shares × price per share. Exact value 83619.8125.

180,040Direct (D) No
F1, F2
  • F1 The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.
  • F2 The weighted average sale price for the transaction reported was $19.1131 and the range of prices were between $18.89 and $19.545. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Open filing 0002048500-26-000012 Read from the filing’s XML Dispute this row
2026-09-02 Filed 2026-09-03Saint Sean Director · Officer: President CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)16,86719.1131
322,380.6577

Derived: shares × price per share. Exact value 322380.6577.

404,070Direct (D) No
F1, F2
  • F1 The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.
  • F2 The weighted average sale price for the transaction reported was $19.1131 and the range of prices were between $18.89 and $19.545. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Open filing 0002048593-26-000009 Read from the filing’s XML Dispute this row
2026-09-02 Filed 2026-09-03Russell Steven Jon Officer: Chief Medical Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)4,22119.1131
80,676.3951

Derived: shares × price per share. Exact value 80676.3951.

169,628Direct (D) No
F1, F2
  • F1 The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.
  • F2 The weighted average sale price for the transaction reported was $19.1131 and the range of prices were between $18.89 and $19.545. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Open filing 0002051384-26-000009 Read from the filing’s XML Dispute this row
2026-06-29 Filed 2026-07-02Feider Stephen Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)4,8965.10
24,969.6

Derived: shares × price per share. Exact value 24969.60.

170,949Direct (D) Yes
F1
  • F1 This Form 4 is being amended to correct the number of shares subject to the option exercise that occurred on June 26, 2026, in connection with the reported sales and to correct the number of securities beneficially owned following the reported transactions.
Open filing 0002048588-26-000010 Read from the filing’s XML Dispute this row
2026-06-29 Filed 2026-07-02Feider Stephen Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)4,89617.0304
83,380.8384

Derived: shares × price per share. Exact value 83380.8384.

166,053Direct (D) Yes
F2, F4, F1
  • F2 Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025.
  • F4 The weighted average sale price for the transaction reported was $17.0304 and the range of prices were between $17 and $17.08. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  • F1 This Form 4 is being amended to correct the number of shares subject to the option exercise that occurred on June 26, 2026, in connection with the reported sales and to correct the number of securities beneficially owned following the reported transactions.
Open filing 0002048588-26-000010 Read from the filing’s XML Dispute this row
2026-06-29 Filed 2026-07-02Feider Stephen Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (4,896) — exercise price 5.10
Disposed (D)4,8960—39,695Direct (D) Yes
F5, F1
  • F5 The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023.
  • F1 This Form 4 is being amended to correct the number of shares subject to the option exercise that occurred on June 26, 2026, in connection with the reported sales and to correct the number of securities beneficially owned following the reported transactions.
Open filing 0002048588-26-000010 Read from the filing’s XML Dispute this row
2026-06-29 Filed 2026-06-30Feider Stephen Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)4,8965.10
24,969.6

Derived: shares × price per share. Exact value 24969.60.

170,827Direct (D) Yes— Open filing 0002048588-26-000009 Read from the filing’s XML Dispute this row
2026-06-29 Filed 2026-06-30Feider Stephen Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)4,89617.0304
83,380.8384

Derived: shares × price per share. Exact value 83380.8384.

165,931Direct (D) Yes
F1, F3
  • F1 Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025.
  • F3 The weighted average sale price for the transaction reported was $17.0304 and the range of prices were between $17 and $17.08. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Open filing 0002048588-26-000009 Read from the filing’s XML Dispute this row
2026-06-29 Filed 2026-06-30Feider Stephen Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (4,896) — exercise price 5.10
Disposed (D)4,8960—39,817Direct (D) Yes
F4
  • F4 The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023.
Open filing 0002048588-26-000009 Read from the filing’s XML Dispute this row
2026-06-26 Filed 2026-07-02Feider Stephen Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)5,1045.10
26,030.4

Derived: shares × price per share. Exact value 26030.40.

171,157Direct (D) Yes
F1
  • F1 This Form 4 is being amended to correct the number of shares subject to the option exercise that occurred on June 26, 2026, in connection with the reported sales and to correct the number of securities beneficially owned following the reported transactions.
Open filing 0002048588-26-000010 Read from the filing’s XML Dispute this row
2026-06-26 Filed 2026-07-02Feider Stephen Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)5,10417.0467
87,006.3568

Derived: shares × price per share. Exact value 87006.3568.

166,053Direct (D) Yes
F2, F3, F1
  • F2 Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025.
  • F3 The weighted average sale price for the transaction reported was $17.046782 and the range of prices were between $17 and $17.12. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  • F1 This Form 4 is being amended to correct the number of shares subject to the option exercise that occurred on June 26, 2026, in connection with the reported sales and to correct the number of securities beneficially owned following the reported transactions.
Open filing 0002048588-26-000010 Read from the filing’s XML Dispute this row
2026-06-26 Filed 2026-07-02Feider Stephen Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (5,104) — exercise price 5.10
Disposed (D)5,1040—44,591Direct (D) Yes
F1, F5
  • F1 This Form 4 is being amended to correct the number of shares subject to the option exercise that occurred on June 26, 2026, in connection with the reported sales and to correct the number of securities beneficially owned following the reported transactions.
  • F5 The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023.
Open filing 0002048588-26-000010 Read from the filing’s XML Dispute this row
2026-06-26 Filed 2026-06-30Feider Stephen Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)4,9825.10
25,408.2

Derived: shares × price per share. Exact value 25408.20.

171,035Direct (D) Yes— Open filing 0002048588-26-000009 Read from the filing’s XML Dispute this row
2026-06-26 Filed 2026-06-30Feider Stephen Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)5,10417.0467
87,006.3568

Derived: shares × price per share. Exact value 87006.3568.

165,931Direct (D) Yes
F1, F2
  • F1 Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 15, 2025.
  • F2 The weighted average sale price for the transaction reported was $17.046782 and the range of prices were between $17 and $17.12. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Open filing 0002048588-26-000009 Read from the filing’s XML Dispute this row
2026-06-26 Filed 2026-06-30Feider Stephen Officer: Chief Financial Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee Stock Option (right to buy) — underlying Common Stock (4,982) — exercise price 5.10
Disposed (D)4,9820—44,713Direct (D) Yes
F4
  • F4 The shares subject to this option shall vest in 48 equal monthly installments measured from September 14, 2023.
Open filing 0002048588-26-000009 Read from the filing’s XML Dispute this row
2026-06-24 Filed 2026-06-25Jones Christy Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,40615
21,090

Derived: shares × price per share. Exact value 21090.

25,994Direct (D) Yes
F1
  • F1 Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on February 19, 2026.
Open filing 0002048467-26-000005 Read from the filing’s XML Dispute this row
2026-06-24 Filed 2026-06-25Hopman Mark Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,25815.0083
18,880.4414

Derived: shares × price per share. Exact value 18880.4414.

129,354Direct (D) Yes
F1, F2
  • F1 Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 13, 2025.
  • F2 The weighted average sale price for the transaction reported was $15.0083 and the range of prices were between $15.00 and $15.015. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Open filing 0002048497-26-000009 Read from the filing’s XML Dispute this row
2026-06-04 Filed 2026-06-05Hopman Mark Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)27512.31
3,385.25

Derived: shares × price per share. Exact value 3385.25.

130,612Direct (D) Yes
F1
  • F1 Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 13, 2025.
Open filing 0002048497-26-000008 Read from the filing’s XML Dispute this row
2026-06-04 Filed 2026-06-05Jones Christy Director
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)2,81114
39,354

Derived: shares × price per share. Exact value 39354.

27,400Direct (D) Yes
F1
  • F1 Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on February 19, 2026.
Open filing 0002048467-26-000004 Read from the filing’s XML Dispute this row
2026-06-02 Filed 2026-06-03Saint Sean Director · Officer: President CEO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)16,87212.6071
212,706.9912

Derived: shares × price per share. Exact value 212706.9912.

420,937Direct (D) No
F1, F2
  • F1 The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.
  • F2 The weighted average sale price for the transaction reported was $12.6071 and the range of prices were between $12.30 and $12.93. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Open filing 0002048593-26-000006 Read from the filing’s XML Dispute this row
2026-06-02 Filed 2026-06-03Hopman Mark Officer: Chief Commercial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)5,32912.6071
67,183.2359

Derived: shares × price per share. Exact value 67183.2359.

130,887Direct (D) No
F1, F2
  • F1 The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.
  • F2 The weighted average sale price for the transaction reported was $12.6071 and the range of prices were between $12.30 and $12.93. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Open filing 0002048497-26-000007 Read from the filing’s XML Dispute this row
2026-06-02 Filed 2026-06-03Mensinger Mike Officer: Chief Product Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)4,37812.6071
55,193.8838

Derived: shares × price per share. Exact value 55193.8838.

184,415Direct (D) No
F1, F2
  • F1 The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.
  • F2 The weighted average sale price for the transaction reported was $12.6071 and the range of prices were between $12.30 and $12.93. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Open filing 0002048500-26-000009 Read from the filing’s XML Dispute this row
2026-06-02 Filed 2026-06-03Feider Stephen Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)6,67612.6071
84,164.9996

Derived: shares × price per share. Exact value 84164.9996.

166,053Direct (D) No
F1, F2
  • F1 The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.
  • F2 The weighted average sale price for the transaction reported was $12.6071 and the range of prices were between $12.30 and $12.93. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Open filing 0002048588-26-000008 Read from the filing’s XML Dispute this row
2026-06-02 Filed 2026-06-03Russell Steven Jon Officer: Chief Medical Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)4,22212.6071
53,227.1762

Derived: shares × price per share. Exact value 53227.1762.

173,849Direct (D) No
F1, F2
  • F1 The shares were sold to cover tax withholding obligations associated with the vesting of restricted stock units.
  • F2 The weighted average sale price for the transaction reported was $12.6071 and the range of prices were between $12.30 and $12.93. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Open filing 0002051384-26-000006 Read from the filing’s XML Dispute this row

Latest reported holdings

What each reporting owner last said they hold, as of the date shown. A transaction not yet filed is not in it.

Latest reported holdings
Reporting ownerSecurityShares owned afterDirect or indirectSource
CARNEY SEAN DirectorDirector Stock Option (right to buy) Derivative security · underlying Common Stock30,456D As of 2025-01-31 Open filing 4
CARNEY SEAN DirectorCommon Stock 32,209D As of 2026-05-21 Open filing 4
Dearen Danny L. DirectorCommon Stock 32,209D As of 2026-05-21 Open filing 4
Feider Stephen Officer: Chief Financial OfficerEmployee Stock Option (right to buy) Derivative security · underlying Common Stock29,695.00D As of 2026-11-11 Open filing 4
Feider Stephen Officer: Chief Financial OfficerCommon Stock 159,378.00D As of 2026-11-11 Open filing 4
Hopman Mark Officer: Chief Commercial OfficerEmployee Stock Option (right to buy) Derivative security · underlying Common Stock20,950.00D As of 2026-11-16 Open filing 4
Hopman Mark Officer: Chief Commercial OfficerCommon Stock 54,143.00D As of 2026-11-16 Open filing 4
Jones Christy DirectorDirector Stock Option (right to buy) Derivative security · underlying Common Stock48,730D As of 2025-01-31 Open filing 4
Jones Christy DirectorCommon Stock 19,564D As of 2026-09-22 Open filing 4
Lezack Adam DirectorDirector Stock Option (right to buy) Derivative security · underlying Common Stock9,137D As of 2025-01-31 Open filing 4
Lezack Adam DirectorCommon Stock 28,397D As of 2026-05-21 Open filing 4
Lezack Adam DirectorComon Stock 27,399D As of 2026-05-22 Open filing 4
MICHEL GERARD J DirectorCommon Stock 33,509D As of 2026-05-21 Open filing 4
Mensinger Mike Officer: Chief Product OfficerClass B Common Stock Warrant (right to buy) Derivative security · underlying Common Stock0D As of 2025-01-31 Open filing 4
Mensinger Mike Officer: Chief Product OfficerEmployee Stock Option (right to buy) Derivative security · underlying Common Stock91,520D As of 2026-02-27 Open filing 4/A
Mensinger Mike Officer: Chief Product OfficerSeries D Preferred Stock Derivative security · underlying Common Stock0D As of 2025-01-31 Open filing 4
Mensinger Mike Officer: Chief Product OfficerCommon Stock 174,740.00D As of 2026-10-27 Open filing 4
Palasis Maria DirectorDirector Stock Option (right to buy) Derivative security · underlying Common Stock9,137D As of 2025-01-31 Open filing 4
Palasis Maria DirectorCommon Stock 29,397D As of 2026-05-21 Open filing 4
Russell Steven Jon Officer: Chief Medical OfficerEmployee Stock Option (right to buy) Derivative security · underlying Common Stock91,520D As of 2026-02-27 Open filing 4/A
Russell Steven Jon Officer: Chief Medical OfficerClass A Common Stock 38,071D As of 2025-01-29 Open filing 3
Russell Steven Jon Officer: Chief Medical OfficerCommon Stock 169,628D As of 2026-09-02 Open filing 4
Saint Sean Director · Officer: President CEOEmployee Stock Option (right to buy) Derivative security · underlying Common Stock287,944D As of 2026-02-27 Open filing 4/A
Saint Sean Director · Officer: President CEOCommon Stock 398,429D As of 2026-09-03 Open filing 4
Wellington Hadley Harbor Aggregator IV, L.P. 10% ownerSeries E Preferred Stock Derivative security · underlying Common Stock0D As of 2025-01-31 Open filing 4
Wellington Hadley Harbor Aggregator IV, L.P. 10% ownerCommon Stock 3,901,599D As of 2025-01-31 Open filing 4

Joint filers each report the same shares, so rows are not added together.

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,935 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,178 filings read.

Showing 1–50 of 157

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
PRICE T ROWE ASSOCIATES INC /MD/ Partly reported under another manager8,943,061 SH169,741 dollarsHigher by 8,899,611 Prior quarter: 43,450Open filing 0000080255-26-000736 Filed 2026-11-16 Dispute this row
EVENTIDE ASSET MANAGEMENT, LLC 7,044,630 SH133,724,910 dollarsHigher by 790,957 Prior quarter: 6,253,673Open filing 0001580642-26-007711 Filed 2026-11-13 Dispute this row
MORGAN STANLEY Partly reported under another manager4,331,446 SH82,210,844 dollarsHigher by 64,624 Prior quarter: 4,266,822Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
Sands Capital Alternatives, LLC 3,997,898 SH75,880,104 dollarsHigher by 289,855 Prior quarter: 3,708,043Open filing 0001846444-26-000013 Filed 2026-11-13 Dispute this row
Soleus Capital Management, L.P. 3,743,714 SH71,055,692 dollarsLower by 650,000 Prior quarter: 4,393,714Open filing 0001802630-26-000008 Filed 2026-11-16 Dispute this row
BlackRock, Inc. Partly reported under another manager3,416,197 SH64,839,419 dollarsHigher by 76,026 Prior quarter: 3,340,171Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 2,238,975 SH42,495,746 dollarsHigher by 456,629 Prior quarter: 1,782,346Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
DEERFIELD MANAGEMENT COMPANY, L.P. Partly reported under another manager1,903,710 SH36,132,416 dollarsHigher by 579,710 Prior quarter: 1,324,000Open filing 0001213900-26-120609 Filed 2026-11-16 Dispute this row
JPMORGAN CHASE CO Partly reported under another manager1,874,993 SH36,393,614 dollarsHigher by 1,171,637 Prior quarter: 703,356Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager1,137,313 SH21,591,669 dollarsHigher by 63,861 Prior quarter: 1,073,452Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
First Light Asset Management, LLC 1,109,420 SH21,056,792 dollarsNot in the prior quarter’s filings read Open filing 0001999371-26-025524 Filed 2026-11-16 Dispute this row
Eversept Partners, LP 1,023,872 SH19,433,091 dollarsLower by 225,569 Prior quarter: 1,249,441Open filing 0001697013-26-000007 Filed 2026-11-16 Dispute this row
STATE STREET CORP Partly reported under another manager1,020,778 SH19,374,366 dollarsHigher by 50,586 Prior quarter: 970,192Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
RTW INVESTMENTS, LP 998,855 SH18,958,268 dollarsLower by 501,145 Prior quarter: 1,500,000Open filing 0001493215-26-000214 Filed 2026-11-16 Dispute this row
Point72 Asset Management, L.P. 967,144 SH18,356,393 dollarsLower by 1,287,539 Prior quarter: 2,254,683Open filing 0000919574-26-008126 Filed 2026-11-16 Dispute this row
Omega Fund Management, LLC 962,010 SH18,258,950 dollarsLower by 354,173 Prior quarter: 1,316,183Open filing 0001193125-26-462150 Filed 2026-11-16 Dispute this row
BANK OF AMERICA CORP /DE/ Partly reported under another manager867,059 SH16,456,779 dollarsHigher by 320,409 Prior quarter: 546,650Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row
D. E. Shaw Co., Inc. Partly reported under another manager781,102 SH14,825,316 dollarsNot in the prior quarter’s filings read Open filing 0001104659-26-128287 Filed 2026-11-16 Dispute this row
Bruce Co., Inc. 665,700 SH12,634,986 dollarsUnchanged Prior quarter: 665,700Open filing 0001104659-26-127888 Filed 2026-11-16 Dispute this row
PERCEPTIVE ADVISORS LLC 538,159 SH10,214,258 dollarsLower by 294,785 Prior quarter: 832,944Open filing 0001012975-26-001063 Filed 2026-11-16 Dispute this row
SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 500,000 SH9,490,000 dollarsNot in the prior quarter’s filings read Open filing 0001172661-26-005064 Filed 2026-11-16 Dispute this row
LORD, ABBETT CO. LLC 466,321 SH8,851 dollarsNot in the prior quarter’s filings read Open filing 0000930413-26-003314 Filed 2026-11-13 Dispute this row
FMR LLC Partly reported under another manager441,139 SH8,372,817 dollarsHigher by 437,627 Prior quarter: 3,512Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 395,182 SH7,500,554 dollarsHigher by 44,309 Prior quarter: 350,873Open filing 0000884546-26-000417 Filed 2026-11-16 Dispute this row
TD ASSET MANAGEMENT INC 392,422 SH7,616,911 dollarsNot in the prior quarter’s filings read Open filing 0001193125-26-460060 Filed 2026-11-13 Dispute this row
Trexquant Investment LP Partly reported under another manager364,455 SH6,917,356 dollarsLower by 129,980 Prior quarter: 494,435Open filing 0001633445-26-000008 Filed 2026-11-16 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager340,893 SH6,470,149 dollarsHigher by 8,937 Prior quarter: 331,956Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
AQR CAPITAL MANAGEMENT LLC Partly reported under another manager312,124 SH5,924,115 dollarsHigher by 3,656 Prior quarter: 308,468Open filing 0001167557-26-000324 Filed 2026-11-16 Dispute this row
VANGUARD FIDUCIARY TRUST CO 302,929 SH5,749,592 dollarsHigher by 35,014 Prior quarter: 267,915Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
GOLDMAN SACHS GROUP INC Partly reported under another manager293,837 SH5,577,026 dollarsLower by 243,268 Prior quarter: 537,105Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row
UBS Group AG Partly reported under another manager293,012 SH5,561,368 dollarsLower by 93,611 Prior quarter: 386,623Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 277,941 SH5,275,320 dollarsHigher by 4,957 Prior quarter: 272,984Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
ING GROEP NV 250,000 SH4,745,000 dollarsNot in the prior quarter’s filings read Open filing 0001140361-26-042914 Filed 2026-11-10 Dispute this row
MANUFACTURERS LIFE INSURANCE COMPANY, THE Partly reported under another manager227,831 SH4,324,232 dollarsHigher by 216,850 Prior quarter: 10,981Open filing 0001145443-26-000111 Filed 2026-11-13 Dispute this row
Mariner, LLC 222,498 SH4,223,013 dollarsHigher by 2,139 Prior quarter: 220,359Open filing 0001580642-26-007648 Filed 2026-11-12 Dispute this row
Invesco Ltd. Partly reported under another manager208,231 SH3,952,225 dollarsHigher by 187,210 Prior quarter: 21,021Open filing 0000914208-26-000462 Filed 2026-11-12 Dispute this row
Granahan Investment Management, LLC 198,616 SH3,769,732 dollarsLower by 101,016 Prior quarter: 299,632Open filing 0001398344-26-020113 Filed 2026-11-16 Dispute this row
BNP PARIBAS FINANCIAL MARKETS Partly reported under another manager189,879 SH3,603,903 dollarsHigher by 179,556 Prior quarter: 10,323Open filing 0001166588-26-000012 Filed 2026-11-12 Dispute this row
TUDOR INVESTMENT CORP ET AL 187,803 SH3,564,501 dollarsHigher by 123,994 Prior quarter: 63,809Open filing 0000902664-26-004567 Filed 2026-11-16 Dispute this row
DIMENSIONAL FUND ADVISORS LP Partly reported under another manager167,503 SH3,180,743 dollarsNot in the prior quarter’s filings read Open filing 0000354204-26-001096 Filed 2026-11-04 Dispute this row
Squarepoint Ops LLC Partly reported under another manager155,884 SH2,958,678 dollarsLower by 5,214 Prior quarter: 161,098Open filing 0001642575-26-000012 Filed 2026-11-09 Dispute this row
Bank of New York Mellon Corp Partly reported under another manager119,605 SH2,270,113 dollarsLower by 3,292 Prior quarter: 122,897Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row
LAZARD ASSET MANAGEMENT LLC 119,233 SH2,263,042 dollarsHigher by 23,679 Prior quarter: 95,554Open filing 0001207017-26-000051 Filed 2026-11-16 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Partly reported under another manager118,794 SH2,254,710 dollarsNot in the prior quarter’s filings read Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
CITADEL ADVISORS LLC Partly reported under another manager103,450 SH1,963,481 dollarsNot in the prior quarter’s filings read Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
AMERIPRISE FINANCIAL INC Partly reported under another manager102,720 SH1,949,626 dollarsNot in the prior quarter’s filings read Open filing 0001193125-26-463125 Filed 2026-11-16 Dispute this row
Nuveen, LLC Partly reported under another manager97,632 SH1,853,055 dollarsHigher by 6,261 Prior quarter: 91,371Open filing 0000930413-26-003284 Filed 2026-11-10 Dispute this row
AMERICAN CENTURY COMPANIES INC Partly reported under another manager92,310 SH1,752,044 dollarsHigher by 76,950 Prior quarter: 15,360Open filing 0000748054-26-000009 Filed 2026-11-20 Dispute this row
Jefferies Financial Group Inc. Partly reported under another manager90,015 SH1,708,485 dollarsNot in the prior quarter’s filings read Open filing 0000096223-26-000034 Filed 2026-11-05 Dispute this row
Archon Capital Management LLC 83,873 SH1,591,910 dollarsHigher by 30,000 Prior quarter: 53,873Open filing 0000919574-26-007832 Filed 2026-11-16 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • Vestal Point Capital, LP 1,600,000 SH
  • Balyasny Asset Management L.P. 855,682 SH
  • FARALLON CAPITAL MANAGEMENT, L.L.C. 595,000 SH
  • Tri Locum Partners LP 493,344 SH
  • HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 409,300 SH
  • Sixth Street Partners Management Company, L.P. 350,873 SH
  • PURA VIDA INVESTMENTS, LLC 281,164 SH
  • Jain Global LLC 172,584 SH
  • Aquatic Capital Management LLC 41,254 SH
  • Brevan Howard Capital Management LP 33,654 SH
  • EntryPoint Capital, LLC 27,372 SH
  • Curated Wealth Partners LLC 20,000 SH
  • Regatta Research Money Management 19,034 SH
  • Caprock Group, LLC 18,346 SH
  • INTREPID FAMILY OFFICE LLC 15,000 SH
  • BROWN ADVISORY INC 11,946 SH
  • Integrated Wealth Concepts LLC 1,370 SH
  • Quarry LP 123 SH
  • Physician Wealth Advisors, Inc. 72 SH
  • FIFTH THIRD BANCORP 29 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text; they are read only when their rows add up to the totals the filer states.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Institutional ownership reported on Form 13F

13F filers report holding between 43.00% and 103.89% of shares outstanding.

Quarter ending 2026-09-30, against 54,367,067 shares on the cover dated 2026-10-26.

  • The lower figure counts positions a manager reports as its own with sole discretion. The upper figure counts every plain-share position and can count a share twice.
  • Neither includes holders that do not file Form 13F, or managers below the filing threshold.
Quarter-by-quarter 13F holders
QuarterManagers holdingShares, at leastShares, at mostFilings read
2026-09-30 15223,375,68956,482,8178,935
2026-06-30 13827,648,54048,368,5829,178
2026-03-31 13127,205,43849,325,0149,173
2025-12-31 15825,082,40747,151,7699,222
2025-09-30 12824,083,94648,488,1228,469
2025-06-30 11726,722,64244,853,5908,516
2025-03-31 10424,002,21141,703,0928,518
2024-12-31 0008,580

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Divisadero Street Capital Management, LP Common Stock, $0.0001 par value per share0.169,443.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 1Open filing 0000919574-26-008148 Dispute this row
William Zolezzi Common Stock, $0.0001 par value per share0.169,443.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 1Open filing 0000919574-26-008148 Dispute this row
Divisadero Street Partners, L.P. Common Stock, $0.0001 par value per share0.169,443.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 1Open filing 0000919574-26-008148 Dispute this row
Divisadero Street Partners GP, LLC Common Stock, $0.0001 par value per share0.169,443.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 1Open filing 0000919574-26-008148 Dispute this row
Divisadero Street Capital, LLC Common Stock, $0.0001 par value per share0.169,443.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 1Open filing 0000919574-26-008148 Dispute this row
Point72 Asset Management, L.P. Common Stock, par value $0.0001 per share1.8967,144.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 1Open filing 0000919574-26-008109 Dispute this row
Point72 Capital Advisors, Inc. Common Stock, par value $0.0001 per share1.8967,144.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 1Open filing 0000919574-26-008109 Dispute this row
Steven A. Cohen Common Stock, par value $0.0001 per share1.8967,144.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 1Open filing 0000919574-26-008109 Dispute this row
Soleus Private Equity Fund II, L.P. Common Stock1.81,003,961.0009/30/2026 Filed 2026-11-09SCHEDULE 13G/AAmendment 3Open filing 0001213900-26-117545 Dispute this row
Soleus Private Equity GP II, LLC Common Stock1.81,003,961.0009/30/2026 Filed 2026-11-09SCHEDULE 13G/AAmendment 3Open filing 0001213900-26-117545 Dispute this row
Soleus PE GP II, LLC Common Stock1.81,003,961.0009/30/2026 Filed 2026-11-09SCHEDULE 13G/AAmendment 3Open filing 0001213900-26-117545 Dispute this row
Soleus Capital Master Fund, L.P. Common Stock6.83,783,237.0009/30/2026 Filed 2026-11-09SCHEDULE 13G/AAmendment 3Open filing 0001213900-26-117545 Dispute this row
Soleus Capital, LLC Common Stock6.83,783,237.0009/30/2026 Filed 2026-11-09SCHEDULE 13G/AAmendment 3Open filing 0001213900-26-117545 Dispute this row
Soleus Capital Group, LLC Common Stock6.83,783,237.0009/30/2026 Filed 2026-11-09SCHEDULE 13G/AAmendment 3Open filing 0001213900-26-117545 Dispute this row
Soleus Capital Management, L.P. Common Stock8.64,787,198.0009/30/2026 Filed 2026-11-09SCHEDULE 13G/AAmendment 3Open filing 0001213900-26-117545 Dispute this row
Soleus GP, LLC Common Stock8.64,787,198.0009/30/2026 Filed 2026-11-09SCHEDULE 13G/AAmendment 3Open filing 0001213900-26-117545 Dispute this row
Levy Guy Common Stock8.74,828,619.0009/30/2026 Filed 2026-11-09SCHEDULE 13G/AAmendment 3Open filing 0001213900-26-117545 Dispute this row
T. Rowe Price Associates, Inc. COMMON STOCK16.68,943,06109/30/2026 Filed 2026-10-07SCHEDULE 13GOpen filing 0000080255-26-000609 Dispute this row
Divisadero Street Capital Management, LP Common Stock, $0.0001 par value per share6.93,072,985.0007/17/2026 Filed 2026-07-24SCHEDULE 13GOpen filing 0000919574-26-004585 Dispute this row
William Zolezzi Common Stock, $0.0001 par value per share6.93,072,985.0007/17/2026 Filed 2026-07-24SCHEDULE 13GOpen filing 0000919574-26-004585 Dispute this row
Divisadero Street Partners, L.P. Common Stock, $0.0001 par value per share5.92,612,985.0007/17/2026 Filed 2026-07-24SCHEDULE 13GOpen filing 0000919574-26-004585 Dispute this row
Divisadero Street Partners GP, LLC Common Stock, $0.0001 par value per share5.92,612,985.0007/17/2026 Filed 2026-07-24SCHEDULE 13GOpen filing 0000919574-26-004585 Dispute this row
Divisadero Street Capital, LLC Common Stock, $0.0001 par value per share6.93,072,985.0007/17/2026 Filed 2026-07-24SCHEDULE 13GOpen filing 0000919574-26-004585 Dispute this row
Farallon Capital Management, L.L.C. Common Stock, $0.0001 par value per share (the "Shares")1.3595,00006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 5Open filing 0000908834-26-000395 Dispute this row
Zone Healthcare Holdings, LLC Common Stock, $0.0001 par value per share (the "Shares")0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 5Open filing 0000908834-26-000395 Dispute this row
Farallon Capital Partners, L.P. Common Stock, $0.0001 par value per share (the "Shares")0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 5Open filing 0000908834-26-000395 Dispute this row
Farallon Capital Institutional Partners, L.P. Common Stock, $0.0001 par value per share (the "Shares")0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 5Open filing 0000908834-26-000395 Dispute this row
Farallon Capital Institutional Partners II, L.P. Common Stock, $0.0001 par value per share (the "Shares")0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 5Open filing 0000908834-26-000395 Dispute this row
Farallon Capital Institutional Partners III, L.P. Common Stock, $0.0001 par value per share (the "Shares")0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 5Open filing 0000908834-26-000395 Dispute this row
Four Crossings Institutional Partners V, L.P. Common Stock, $0.0001 par value per share (the "Shares")0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 5Open filing 0000908834-26-000395 Dispute this row
Farallon Capital Offshore Investors II, L.P. Common Stock, $0.0001 par value per share (the "Shares")0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 5Open filing 0000908834-26-000395 Dispute this row
Farallon Capital (AM) Investors, L.P. Common Stock, $0.0001 par value per share (the "Shares")0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 5Open filing 0000908834-26-000395 Dispute this row
Farallon Capital F5 Master I, L.P. Common Stock, $0.0001 par value per share (the "Shares")0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 5Open filing 0000908834-26-000395 Dispute this row
Farallon Partners, L.L.C. Common Stock, $0.0001 par value per share (the "Shares")0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 5Open filing 0000908834-26-000395 Dispute this row
Farallon Institutional (GP) V, L.L.C. Common Stock, $0.0001 par value per share (the "Shares")0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 5Open filing 0000908834-26-000395 Dispute this row
Farallon F5 (GP), L.L.C. Common Stock, $0.0001 par value per share (the "Shares")0006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 5Open filing 0000908834-26-000395 Dispute this row
Dapice Joshua J. Common Stock, $0.0001 par value per share (the "Shares")1.3595,00006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 5Open filing 0000908834-26-000395 Dispute this row
Dreyfuss, Philip D. Common Stock, $0.0001 par value per share (the "Shares")1.3595,00006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 5Open filing 0000908834-26-000395 Dispute this row
Dunn Hannah E. Common Stock, $0.0001 par value per share (the "Shares")1.3595,00006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 5Open filing 0000908834-26-000395 Dispute this row
Gehani, Varun N. Common Stock, $0.0001 par value per share (the "Shares")1.3595,00006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 5Open filing 0000908834-26-000395 Dispute this row
Giauque, Nicolas Common Stock, $0.0001 par value per share (the "Shares")1.3595,00006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 5Open filing 0000908834-26-000395 Dispute this row
Husen, Avner A. Common Stock, $0.0001 par value per share (the "Shares")1.3595,00006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 5Open filing 0000908834-26-000395 Dispute this row
Kim, David T. Common Stock, $0.0001 par value per share (the "Shares")1.3595,00006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 5Open filing 0000908834-26-000395 Dispute this row
Linn, Michael G. Common Stock, $0.0001 par value per share (the "Shares")1.3595,00006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 5Open filing 0000908834-26-000395 Dispute this row
Luo Patrick (Cheng) Common Stock, $0.0001 par value per share (the "Shares")1.3595,00006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 5Open filing 0000908834-26-000395 Dispute this row
Roberts, Jr., Thomas G. Common Stock, $0.0001 par value per share (the "Shares")1.3595,00006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 5Open filing 0000908834-26-000395 Dispute this row
Saito Edric C. Common Stock, $0.0001 par value per share (the "Shares")1.3595,00006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 5Open filing 0000908834-26-000395 Dispute this row
Short Daniel S. Common Stock, $0.0001 par value per share (the "Shares")1.3595,00006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 5Open filing 0000908834-26-000395 Dispute this row
Spokes, Andrew J. M. Common Stock, $0.0001 par value per share (the "Shares")1.3595,00006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 5Open filing 0000908834-26-000395 Dispute this row
Warren, John R. Common Stock, $0.0001 par value per share (the "Shares")1.3595,00006/30/2026 Filed 2026-08-13SCHEDULE 13G/AAmendment 5Open filing 0000908834-26-000395 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,808,053 filings read, dated 1999-04-30 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015218,057
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,828

Filings made before the SEC required XML are listed, not extracted.

Back to Beta Bionics, Inc.